J&J vaccine may cause Guillain-Barré Syndrome, warns FDA

  The Food and Drug Administration (FDA) states that Guillain-Barré Syndrome (GBS) is a potential adverse effect of the Johnson & Johnson COVID-19 vaccine. According to the agency, there have been 100 reports of the rare but serious neurological disorder, following vaccination with said vaccine as of July 13. GBS causes inflammation of the nerves which can lead to sudden muscle weakness and … Continue reading J&J vaccine may cause Guillain-Barré Syndrome, warns FDA